142 related articles for article (PubMed ID: 2884839)
1. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis.
Barral-Netto M; Cardoso SA; Barral A
Acta Trop; 1987 Mar; 44(1):5-11. PubMed ID: 2884839
[TBL] [Abstract][Full Text] [Related]
2. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages.
Reis MG; Roters SB; Barral-Netto M
Acta Trop; 1987 Sep; 44(3):339-42. PubMed ID: 2892370
[TBL] [Abstract][Full Text] [Related]
3. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
4. Leishmania amazonensis: humoral response to amastigote excreted-antigens in murine leishmaniasis.
Hernández-Chinea C
Exp Parasitol; 2007 Aug; 116(4):492-6. PubMed ID: 17349625
[TBL] [Abstract][Full Text] [Related]
5. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice.
Barral-Netto M; de Freitas LA; Andrade ZA
Am J Pathol; 1987 May; 127(2):271-8. PubMed ID: 3495185
[TBL] [Abstract][Full Text] [Related]
6. Infection of BALB/c, C57B1/6 mice and F1 hybrid CB6F1 mice with strains of Leishmania mexicana isolated from Mexican patients with localized or diffuse cutaneous leishmaniasis.
Monroy-Ostria A; Fuentes-Fraga I; García-Flores C; Favila-Castillo L
Arch Med Res; 1994; 25(4):401-6. PubMed ID: 7858398
[TBL] [Abstract][Full Text] [Related]
7. Leishsmania (Leishmania) amazonensis infection: Muscular involvement in BALB/c and C3H.HeN mice.
Silva-Almeida M; Carvalho LO; Abreu-Silva AL; d'Escoffier LN; Calabrese KS
Exp Parasitol; 2010 Mar; 124(3):315-8. PubMed ID: 19944691
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing the host response to Leishmania mexicana.
Pérez H
Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
[TBL] [Abstract][Full Text] [Related]
9. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
[TBL] [Abstract][Full Text] [Related]
10. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
11. [Independence of the delayed hypersensitivity response from protection against Leishmania mexicana pifanoi].
Pérez HA; De la Rora M
Acta Cient Venez; 1986; 37(5):542-6. PubMed ID: 2966535
[No Abstract] [Full Text] [Related]
12. Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana.
Dissanayake S; Shahin A; Ameen AM
Mol Immunol; 2005 Aug; 42(12):1495-502. PubMed ID: 15950742
[TBL] [Abstract][Full Text] [Related]
13. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes.
Felizardo TC; Toma LS; Borges NB; Lima GM; Abrahamsohn IA
Parasitology; 2007 Nov; 134(Pt 12):1699-707. PubMed ID: 17655808
[TBL] [Abstract][Full Text] [Related]
14. The effects of protein malnutrition on the course of Leishmania mexicana infection in C57Bl/6 mice: nutrition and susceptibility to leishmaniasis.
Pérez H; Malavé I; Arredondo B
Clin Exp Immunol; 1979 Dec; 38(3):453-60. PubMed ID: 535184
[TBL] [Abstract][Full Text] [Related]
15. Early infection with Leishmania major restrains pathogenic response to Leishmania amazonensis and parasite growth.
González-Lombana CZ; Santiago HC; Macedo JP; Seixas VA; Russo RC; Tafuri WL; Afonso LC; Vieira LQ
Acta Trop; 2008 Apr; 106(1):27-38. PubMed ID: 18313021
[TBL] [Abstract][Full Text] [Related]
16. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity.
Titus RG; Lima GC; Engers HD; Louis JA
J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088
[TBL] [Abstract][Full Text] [Related]
18. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis.
Scott P; Sacks D; Sher A
J Immunol; 1983 Aug; 131(2):966-71. PubMed ID: 6863939
[TBL] [Abstract][Full Text] [Related]
19. Leishmania mexicana lipophosphoglycan differentially regulates PKCalpha-induced oxidative burst in macrophages of BALB/c and C57BL/6 mice.
Delgado-Domínguez J; González-Aguilar H; Aguirre-García M; Gutiérrez-Kobeh L; Berzunza-Cruz M; Ruiz-Remigio A; Robles-Flores M; Becker I
Parasite Immunol; 2010 Jun; 32(6):440-9. PubMed ID: 20500675
[TBL] [Abstract][Full Text] [Related]
20. Influence of long-term treatment with pravastatin on the survival, evolution of cutaneous lesion and weight of animals infected by Leishmania amazonensis.
Kückelhaus CS; Kückelhaus SA; Muniz-Junqueira MI
Exp Parasitol; 2011 Mar; 127(3):658-64. PubMed ID: 21176775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]